V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004498 | 290003300 | 1.7 | 62.8 | Neo-adjuvant (N) | 2017-03-22 | 2017-04-13 | Capecitabine | N | N | 290021296 | TRIAL |
| 290004499 | 290003301 | 1.76 | 58 | Palliative (P) | 2014-08-27 | 2014-09-02 | Carboplatin + Etoposide iv&po | 02 | N | 290021298 | CVP R |
| 290004500 | 290003301 | 1.67 | 89 | Adjuvant (A) | 2015-10-23 | 2015-10-23 | CISPLATIN + FLUOROURACIL | N | N | 290021298 | OCTREOTIDE |
| 290004501 | 290003302 | 1.79 | 62.4 | Curative (C) | 2014-03-23 | 2014-03-23 | IBRUTINIB | 2 | N | 290021301 | CAPECITABINE |
| 290004502 | 290003303 | 1.73 | 55.5 | Palliative (P) | 2017-06-25 | 2017-06-25 | LANREOTIDE | 02 | N | 290021303 | LANREOTIDE |
| 290004503 | 290003303 | 1.66 | 92 | Palliative (P) | 2015-10-21 | 2015-11-08 | Trial Unspecified | N | N | 290021303 | CISPLATIN + FLUOROURACIL |
| 290004504 | 290003304 | 1.91 | 84 | Palliative (P) | 2017-07-31 | 2017-08-01 | Carboplatin + Etoposide iv&po | 2 | N | 290021306 | CARBO + FLUOROURACIL |
| 290004505 | 290003305 | 1.77 | 90 | Curative (C) | 2014-10-26 | 2014-11-23 | CISPLATIN + FLUOROURACIL | N | N | 290021310 | CETUXIMAB + RT |
| 290004506 | 290003306 | 1.52 | null | Palliative (P) | 2018-01-15 | 2018-01-15 | CARBOPLATIN + RT | 2 | N | 290021312 | OCTREOTIDE |
| 290004507 | 290006498 | 1.68 | 61.9 | null | 2016-01-27 | 2016-02-21 | Capecitabine | N | N | 290021315 | CAPECITABINE + RT |
| 290004508 | 290006498 | 1.48 | 37 | Curative (C) | null | 2014-10-23 | LANREOTIDE | N | N | 290021315 | CHOP R |
| 290004509 | 290003307 | 1.69 | 80.2 | null | 2016-04-26 | 2016-05-17 | MITOMYCIN | N | N | 290021319 | CARBOPLATIN + RT |
| 290004510 | 290003308 | null | 110 | Palliative (P) | 2014-10-23 | 2014-10-26 | GEMCITABINE | N | N | 290021321 | FLUOROURACIL |
| 290004511 | 290003309 | 1.81 | null | null | 2014-05-14 | 2014-06-14 | CISPLATIN + FLUOROURACIL | 02 | N | 290021322 | CAPECITABINE |
| 290004512 | 290003310 | 1.67 | 62 | Not known (9) | 2015-02-01 | 2015-02-01 | CARBOPLATIN + RT | 02 | N | 290021324 | LANREOTIDE |
| 290004513 | 290003311 | 1.91 | 75.3 | Neo-adjuvant (N) | 2015-11-03 | 2015-11-22 | Capecitabine 35days + RT | N | N | 290021325 | CAPECITABINE + TEMOZOLOMIDE |
| 290004514 | 290003312 | 1.67 | 74.1 | Palliative (P) | 2014-02-10 | 2014-02-11 | Cetuximab + Radiotherapy Maint | 02 | N | 290021326 | ETOPOSIDE |
| 290004515 | 290003313 | null | 80 | Palliative (P) | 2015-02-21 | 2015-02-24 | Fluorouracil + Folinic Acid Weekly | 2 | N | 290021328 | CISPLATIN + ETOPOSIDE |
| 290004516 | 290003314 | 0 | 83.3 | Palliative (P) | 2013-12-25 | 2013-12-31 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 290021329 | LANREOTIDE |
| 290004517 | 290003315 | 1.55 | null | null | 2016-07-22 | 2016-07-24 | LANREOTIDE | 02 | null | 290021330 | CISPLATIN + FLUOROURACIL |
| 290004518 | 290003316 | 1.76 | 97.8 | Curative (C) | 2013-12-09 | 2013-12-09 | Capecitabine | 02 | N | 290021331 | IRINOTECAN + MDG |
| 290004519 | 290003316 | 1.8 | 108 | Adjuvant (A) | 2013-08-03 | 2013-08-13 | LANREOTIDE | N | N | 290021331 | LANREOTIDE |
| 290004520 | 290003317 | 1.77 | 82.5 | Palliative (P) | 2015-06-25 | 2015-07-27 | Carboplatin + Pemetrexed | 01 | N | 290021333 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004521 | 290003318 | 1.74 | 67.9 | null | 2014-12-27 | 2014-12-31 | MCX | 2 | N | 290021334 | LANREOTIDE |
| 290004522 | 290003319 | 1.65 | 56.4 | Not known (9) | null | 2014-07-11 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 290021335 | TRIAL |
| 290004523 | 290006500 | 1.64 | 60.9 | Curative (C) | 2018-01-31 | 2018-01-31 | Capecitabine | null | null | 290021336 | CETUXIMAB + RT |
| 290004524 | 290003320 | 1.76 | 97.2 | Palliative (P) | 2017-03-23 | 2017-03-29 | CAPECITABINE + RT | N | N | 290021338 | FLUOROURACIL |
| 290004525 | 290003321 | 1.76 | 65 | Palliative (P) | 2018-01-07 | 2018-01-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021340 | CAPECITABINE + STREPTOZOCIN |
| 290004526 | 290003322 | 1.7 | 76 | null | 2016-05-11 | 2016-05-16 | Irinotecan + Modified De Gramont | N | N | 290021341 | CETUXIMAB |
| 290004527 | 290003323 | 1.88 | 140.8 | Curative (C) | 2015-01-21 | 2015-01-21 | EOX | 2 | N | 290021342 | PEMBROLIZUMAB |
| 290004528 | 290006501 | 1.69 | 74.9 | Palliative (P) | 2016-07-31 | 2016-08-06 | Bevacizumab + Oxaliplatin +MdG | N | N | 290021343 | CISPLATIN + FLUOROURACIL |
| 290004529 | 290003324 | null | null | Palliative (P) | 2019-03-24 | 2019-03-30 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290021345 | CAPECITABINE + CARBOPLATIN |
| 290004530 | 290003325 | 1.73 | 57 | Curative (C) | 2016-07-16 | 2016-07-30 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290021346 | CAPECITABINE |
| 290004531 | 290003326 | null | 63.9 | Palliative (P) | 2016-07-23 | 2016-08-12 | OCTREOTIDE | N | N | 290021347 | CISPLATIN + GEMCITABINE |
| 290004532 | 290003327 | 1.67 | 60 | Disease modification (D) | 2013-04-20 | 2013-04-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021352 | CAPECITABINE + RT |
| 290004533 | 290003328 | null | 59.6 | Neo-adjuvant (N) | 2013-06-09 | 2013-06-21 | Mitomycin Intravesical | 02 | N | 290021357 | LANREOTIDE |
| 290004534 | 290003328 | 1.88 | 86.5 | Adjuvant (A) | 2015-06-08 | 2015-07-04 | LANREOTIDE | N | Y | 290021357 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004535 | 290003329 | null | 64.2 | Palliative (P) | 2016-03-12 | 2016-04-01 | CARBOPLATIN | 02 | N | 290021359 | LANREOTIDE |
| 290004536 | 290003330 | null | 91.9 | Curative (C) | 2017-06-23 | 2017-06-29 | Capecitabine | 2 | Y | 290021362 | CARBOPLATIN + RT |
| 290004537 | 290003331 | 1.8 | 76.74 | Disease modification (D) | 2017-02-10 | 2017-02-23 | Capecitabine 35days + RT | 02 | N | 290021363 | PLATO TRIAL |
| 290004538 | 290003332 | 1.63 | 101 | null | 2014-12-06 | 2014-12-06 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290021369 | IPILIMUMAB |
| 290004539 | 290003333 | 1.66 | 78.8 | null | null | 2018-03-12 | CHOP R - 21 days | N | N | 290021371 | IRINOTECAN + MDG |
| 290004540 | 290003334 | 1.56 | 78.8 | Adjuvant (A) | 2008-03-31 | 2013-06-01 | Capecitabine | 02 | N | 290021373 | CAPECITABINE |
| 290004541 | 290003334 | 1.69 | 96.5 | Palliative (P) | 2013-08-05 | 2013-08-14 | Cisplatin + Fluorouracil + RT 5day | 01 | N | 290021373 | LANREOTIDE |
| 290004542 | 290003335 | 1.68 | 48.3 | Adjuvant (A) | 2017-09-15 | 2017-09-15 | FLUOROURACIL + IRINOTECAN | 02 | null | 290021380 | CAPECITABINE + RT |
| 290004543 | 290003336 | 1.8 | 50 | Palliative (P) | null | 2017-01-08 | Azacitidine | 2 | N | 290021382 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004544 | 290003336 | 1.73 | 84 | Curative (C) | 2016-11-13 | 2016-11-25 | Capecitabine + Streptozocin | 02 | null | 290021382 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004545 | 290003336 | 1.6 | 65 | Palliative (P) | null | 2016-08-11 | ECX | N | N | 290021382 | GEMCARBO |
| 290004546 | 290008185 | 1.73 | 79.2 | Curative (C) | 2017-01-31 | 2017-02-10 | Carboplatin + Etoposide iv&po | 01 | N | 290021386 | CETUXIMAB |
| 290004547 | 290003337 | 1.86 | 101 | null | 2017-10-15 | 2017-10-18 | OCTREOTIDE | 2 | null | 290021387 | LANREOTIDE |